Aromatase inhibitors – Adon Health Skip to content
Hervorragend
4,6/5
10.000+ Männern geholfen
Cart

Aromatase inhibitors

What are aromatase inhibitors?

Aromatase inhibitors are medications or substances that block the enzyme aromatase. This enzyme is responsible for converting male sex hormones like testosterone into estrogens. By inhibiting aromatase, this conversion can be reduced, leading to a decrease in estrogen levels and a potential increase in testosterone levels.

In medicine, aromatase inhibitors are primarily used to treat hormone-dependent diseases, such as certain forms of breast cancer. In men's health, they play a role mainly when an elevated estrogen level leads to hormonal symptoms. These include gynecomastia, loss of libido, or hormonal imbalances associated with testosterone deficiency.

However, it is important that aromatase inhibitors should only be used under medical supervision. Estrogen levels that are too low can also cause health problems, as estrogens also perform important functions for bones, blood vessels, and metabolism in men.

How do aromatase inhibitors work?

Aromatase inhibitors block the aromatase enzyme, thereby preventing the conversion of androgens into estrogens. The main effect is that less testosterone is converted into estradiol.

The hormonal effects can include:

  • Reduction of estrogen levels
  • Increase in testosterone levels
  • Changes in hormonal balance
  • Possible improvement of certain hormonal symptoms

The effect heavily depends on the individual's initial hormonal situation.

What types of aromatase inhibitors are there?

Various active ingredients are used in medicine to inhibit aromatase activity.

The most well-known include:

  • Anastrozole
  • Letrozole
  • Exemestane

These medications are primarily used in oncology, but in certain cases, they can also be used in men as part of hormonal therapies.

When are aromatase inhibitors used in men?

In men, aromatase inhibitors can be used in specific situations, for example, when there is a hormonal imbalance and estrogen levels are significantly elevated relative to testosterone.

Possible areas of application include:

  • pronounced gynecomastia
  • hormonal imbalance with elevated estradiol
  • certain forms of testosterone deficiency
  • hormonal side effects of testosterone replacement therapy

In practice, however, aromatase inhibitors are used significantly less frequently than other therapeutic measures. Often, lifestyle adjustments or treating the underlying problem takes precedence.

What risks can aromatase inhibitors have?

Excessive inhibition of aromatase can lead to excessively low estrogen levels. Since estrogens also perform important functions for men, this can cause various side effects.

Possible risks include:

  • reduced bone density
  • joint pain
  • negative effects on fat metabolism
  • mood swings
  • reduced libido

Therefore, treatment with aromatase inhibitors should always be accompanied by regular laboratory tests.

What factors influence aromatase activity?

Not every elevated estrogen level requires drug therapy. Often, aromatase activity can be influenced by lifestyle factors.

Key factors include:

  • body fat percentage
  • insulin resistance and metabolic disorders
  • alcohol consumption
  • chronic inflammation
  • certain medications

In particular, visceral fat tissue produces a lot of aromatase. Therefore, weight loss can often lead to an improvement in hormonal balance.

Conclusion

Aromatase inhibitors are medications that reduce the conversion of testosterone to estrogen. They can be used in certain medical situations when there is a hormonal imbalance or when elevated estrogen levels cause symptoms.

Since estrogens also perform important functions in men, the use of these medications should always be carefully considered and medically monitored. In many cases, lifestyle measures such as weight reduction, exercise, and an improvement in metabolism can already contribute to stabilizing hormonal balance.

Sources

  1. Leder, B. Z., et al. (2004). Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. Journal of Clinical Endocrinology and Metabolism, 89(3), 1174-1180. https://doi.org/10.1210/jc.2003-031467
  2. Dias, J. P., et al. (2016). Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial. Andrology, 4(1), 33-40. https://doi.org/10.1111/andr.12126
  3. T'Sjoen, G. G., et al. (2005). Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition. Journal of Clinical Endocrinology and Metabolism, 90(10), 5717-5722. https://doi.org/10.1210/jc.2005-0982
  4. de Ronde, W., & de Jong, F. H. (2011). Aromatase inhibitors in men: effects and therapeutic options. Reproductive Biology and Endocrinology, 9, 93. https://doi.org/10.1186/1477-7827-9-93